These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 19726478)
1. A neurochemical approach to valuation sensitivity over gains and losses. Zhong S; Israel S; Xue H; Sham PC; Ebstein RP; Chew SH Proc Biol Sci; 2009 Dec; 276(1676):4181-8. PubMed ID: 19726478 [TBL] [Abstract][Full Text] [Related]
2. Imaging genetics for utility of risks over gains and losses. Zhong S; Chark R; Ebstein RP; Chew SH Neuroimage; 2012 Jan; 59(1):540-6. PubMed ID: 21801841 [TBL] [Abstract][Full Text] [Related]
3. Asymmetric valuation of gains and losses in effort-based decision making. O'Brien MK; Ahmed AA PLoS One; 2019; 14(10):e0223268. PubMed ID: 31613891 [TBL] [Abstract][Full Text] [Related]
4. Risk-seeking for losses is associated with 5-HTTLPR, but not with transient changes in 5-HT levels. Neukam PT; Kroemer NB; Deza Araujo YI; Hellrung L; Pooseh S; Rietschel M; Witt SH; Schwarzenbolz U; Henle T; Smolka MN Psychopharmacology (Berl); 2018 Jul; 235(7):2151-2165. PubMed ID: 29730700 [TBL] [Abstract][Full Text] [Related]
5. An interaction between the serotonin transporter promoter region and dopamine transporter polymorphisms contributes to harm avoidance and reward dependence traits in normal healthy subjects. Kim SJ; Kim YS; Lee HS; Kim SY; Kim CH J Neural Transm (Vienna); 2006 Jul; 113(7):877-86. PubMed ID: 16604301 [TBL] [Abstract][Full Text] [Related]
6. Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms. Güzey C; Scordo MG; Spina E; Landsem VM; Spigset O Eur J Clin Pharmacol; 2007 Mar; 63(3):233-41. PubMed ID: 17225991 [TBL] [Abstract][Full Text] [Related]
7. Disentangling the effects of serotonin on risk perception: S-carriers of 5-HTTLPR are primarily concerned with the magnitude of the outcomes, not the uncertainty. Millroth P; Juslin P; Eriksson E; Agren T Behav Neurosci; 2017 Oct; 131(5):421-27. PubMed ID: 28805431 [TBL] [Abstract][Full Text] [Related]
8. Dissociable effects of dopamine and serotonin on reversal learning. den Ouden HE; Daw ND; Fernandez G; Elshout JA; Rijpkema M; Hoogman M; Franke B; Cools R Neuron; 2013 Nov; 80(4):1090-100. PubMed ID: 24267657 [TBL] [Abstract][Full Text] [Related]
9. Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making. Kohno M; Nurmi EL; Laughlin CP; Morales AM; Gail EH; Hellemann GS; London ED Neuropsychopharmacology; 2016 Feb; 41(3):695-703. PubMed ID: 26119471 [TBL] [Abstract][Full Text] [Related]
10. Polymorphism of dopamine transporter gene DAT1 and individual variability of defense cardiac response in humans. Aftanas LI; Loktev KV; Miroshnikova PV; Gafarov VV; Gromova EA Bull Exp Biol Med; 2014 Apr; 156(6):845-8. PubMed ID: 24824713 [TBL] [Abstract][Full Text] [Related]
11. Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude. Sharp ME; Viswanathan J; McKeown MJ; Appel-Cresswell S; Stoessl AJ; Barton JJ Neuropsychologia; 2013 Nov; 51(13):2679-89. PubMed ID: 23954375 [TBL] [Abstract][Full Text] [Related]
12. Auditory event-related potentials (P3a, P3b) and genetic variants within the dopamine and serotonin system in healthy females. Heitland I; Kenemans JL; Oosting RS; Baas JM; Böcker KB Behav Brain Res; 2013 Jul; 249():55-64. PubMed ID: 23619133 [TBL] [Abstract][Full Text] [Related]
13. [Risk-taking in adolescence: A neuroeconomics approach]. Barbalat G; Domenech P; Vernet M; Fourneret P Encephale; 2010 Apr; 36(2):147-54. PubMed ID: 20434632 [TBL] [Abstract][Full Text] [Related]
14. Risk taking for potential losses but not gains increases with time of day. Bedder RL; Vaghi MM; Dolan RJ; Rutledge RB Sci Rep; 2023 Apr; 13(1):5534. PubMed ID: 37015952 [TBL] [Abstract][Full Text] [Related]
15. Prospect theory on the brain? Toward a cognitive neuroscience of decision under risk. Trepel C; Fox CR; Poldrack RA Brain Res Cogn Brain Res; 2005 Apr; 23(1):34-50. PubMed ID: 15795132 [TBL] [Abstract][Full Text] [Related]
16. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Jacobsen LK; Staley JK; Zoghbi SS; Seibyl JP; Kosten TR; Innis RB; Gelernter J Am J Psychiatry; 2000 Oct; 157(10):1700-3. PubMed ID: 11007732 [TBL] [Abstract][Full Text] [Related]
17. Genetic variation of dopamine and serotonin function modulates the feedback-related negativity during altruistic punishment. Enge S; Mothes H; Fleischhauer M; Reif A; Strobel A Sci Rep; 2017 Jun; 7(1):2996. PubMed ID: 28592831 [TBL] [Abstract][Full Text] [Related]
19. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients. Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920 [TBL] [Abstract][Full Text] [Related]
20. Decision-making for risky gains and losses among college students with Internet gaming disorder. Yao YW; Chen PR; Li S; Wang LJ; Zhang JT; Yip SW; Chen G; Deng LY; Liu QX; Fang XY PLoS One; 2015; 10(1):e0116471. PubMed ID: 25615595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]